Latest From Scrip Team
Pipeline Watch: Six Approvals And 26 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Changes At The Top At Aileron, KalVista And More
Recent moves in the industry include new chief medical officers at Rigel Pharmaceuticals and FibroGen, while Aileron Therapeutics and KalVista get new CEOs.
Pipeline Watch: Six Approvals And 18 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: New CEOs At Nicox, Maxion Therapeutics And Fore Biotherapeutics
Other recent moves in the industry include 10 new chief financial officers, while Mithra Pharmaceuticals gets two co-chief executives officers.
Publisher’s Spotlight: Citeline News And Insights App
Introducing the all-new Citeline News and Insights app, providing seamless access to all your favorite award-winning publications. Explore the latest articles from Pink Sheet, Scrip, In Vivo, Medtech Insight, Generics Bulletin and HBW Insight, all in one stylish, intuitive and user-friendly platform.
Pipeline Watch: Four Approvals And 21 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.